Skip to main content
Log in

Introduction: Nifedipine and cardioprotection

  • Nifedipine, Cardioprotection, and Ischemic Heart Disease
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kloner RA. Calcium channel blockade during ischemiareperfusion sequences.J Mol Cell Cardiol 1988;20:457.

    PubMed  Google Scholar 

  2. Rademaker M, Meyrick Thomas RH, Kirby JDT, et al. Altered in vitro hemostasis, clotting, and thrombolysis after oral nifedipine in normal volunteers.Anesthesiology 1988; 39:747–751.

    Google Scholar 

  3. The Israeli Spring Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT), a randomized intervention trial on nifedipine in patients with acute myocardial infarction.Eur Heart J 1988;9:354–364.

    Google Scholar 

  4. Leisch F, Schutzenberger W, Kerschner K, et al. Systemic thrombolysis and percutaneous transluminal coronary angioplasty in acute myocardial infarction.Ann Med Intern 1988;139:115–117.

    Google Scholar 

  5. Hess ML, Manson NH. Molecular oxygen: Friend or foe: the role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia of reperfusion injury.J Mol Cell Cardiol 1984;16:969–985.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strano, A. Introduction: Nifedipine and cardioprotection. Cardiovasc Drug Ther 4 (Suppl 5), 877 (1990). https://doi.org/10.1007/BF02018285

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02018285

Navigation